Animal and human tissue Na,K-ATPase in normal and insulin-resistant states: Regulation, behaviour and interpretative hypothesis on NEFA effects

Obesity Reviews

Volumn 8, Issue 3, 2007, Pages 231-251

  Iannello, S ^a,b   Milazzo, P ^a   Belfiore, F ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE   (Italy)

Author keywords

Diabetes; Hypertension; K ATPase; Obesity; Tissue Na

Indexed keywords

ADDUCIN; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ARACHIDONIC ACID; C PEPTIDE; CATECHOLAMINE; CYTOCHROME P450; DOPAMINE; FATTY ACID; FRUCTOSE; GLUCAGON; GROWTH HORMONE; INSULIN; LEPTIN; MAGNESIUM OXIDE; POTASSIUM; PROGESTERONE; SEROTONIN; STEROID HORMONE; STREPTOZOCIN; SUCROSE; THYROID HORMONE; VASOPRESSIN;

ADIPOSE TISSUE; BLOOD PRESSURE; BODY MASS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENERGY BALANCE; ENERGY EXPENDITURE; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; GENETIC SUSCEPTIBILITY; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; LIVER; METABOLIC SYNDROME X; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; REVIEW; SALT INTAKE; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; THERMOGENESIS; ZUCKER RAT;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; NA(+)-K(+)-EXCHANGING ATPASE; OBESITY;

EID: 34247389314     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2006.00276.x     Document Type: Review

References (230)

1. Skou JC. Enzymatic basis for active transport of Na+ and K+ across cell membrane. Physiol Rev 1965 45: 596 617.
2. Sweadner K, Goldin SM. Active transport of sodium and potassium ions. N Engl J Med 1980 302: 777 783.
3. Dahl JL, Hokin LE. The sodium-potassium adenosine-triphosphatase. Annu Rev Biochem 1974 43: 327 356.
4. Schwartz A, Lindenmayer GE, Allen JC. The sodium-potassium adenosine-triphosphatase: pharmacological, physiological and biochemical aspects. Pharmacol Rev 1975 27: 3 134.
5. Newsholme EA, Crabtree B. Substrate cycles in metabolic regulation and in heat generation. Biochem Soc Symp 1976 41: 61 109.
6. Belfiore F, Iannello S. Substrate cycles and the pathogenesis of obesity. J Mol Med 1979 4: 257 270.
7. Katz AI. Role of Na-K-ATPase in kidney function. In: Skou JC, Norby JG, Maunsbach AB, Esmann M (eds). The Na+,K+-Pump, Part B: Cellular Aspects. Alan R Liss Inc: New York, 1988, pp. 207 221.
8. Buffin Meyer B, Deschenes G, Doucet A. Renal K-ATPases: structure, function and dysfunction [French]. Nephrologie 1999 20: 319 327.
9. Hernandez RJ. Na+,K+-ATPase regulation by neurotransmitters. Neurochem Int 1992 20: 1 10.
10. Schwartz A, Grupp G, Wallick E, Grupp IL, Ball WJ Jr. Overview: role of the Na+-K+-ATPase in the cardiotonic action of cardiac glycosides. In: Skou JC, Norby JG, Maunsbach AB, Esmann M (eds). The Na+,K+-Pump, Part B: Cellular Aspects. Alan R Liss Inc: New York, 1988, pp. 321 338.
11. Proverbio F, Shoemaker DG, Hoffman JF. Functional consequences of the membrane pool of ATP associated with the human red blood cell Na/K pump. In: Skou JC, Norby JG, Maunsbach AB, Esmann M (eds). The Na+,K+-Pump, Part B: Cellular Aspects. Alan R Liss Inc: New York, 1988, pp. 561 567.
12. Schrier SL. Organization of enzymes in human erythrocyte membranes. Am J Physiol 1966 210: 139 145.
13. Parker JC, Hoffman JF. The role of membrane phosphoglycerate kinase in the control of glycolytic rate by active transport in human red blood cells. J Gen Physiol 1967 50: 893 916.
14. Bertuccio CA, Cheng SX, Arrizurieta EE, Martin RS, Ibarra FR. Mechanisms of Na+-K+-ATPase phosphorylation by PKC in the medullary thick ascending limb of Henle in the rat. Pflugers Arch 2003 447: 87 96.
15. Ismail Beigi F, Edelman IS. The mechanism of the calorigenic action of thyroid hormone. Stimulation of Na+,K+-activated ATPase activity. J Gen Physiol 1971 57: 710 722.
16. Asano Y, Liberman UA, Edelman IS. Thyroid thermogenesis. Relationships between Na-dependent respiration and Na,K-adenosine triphosphatase activity in rat skeletal muscle. J Clin Invest 1976 57: 368 379.
17. Lo CS, August TR, Liberman UA, Edelman IS. Dependence of renal Na,K-adenosine triphosphatase activity on thyroid status. J Biol Chem 1976 251: 7826 7833.
18. Guernsey DL, Stevens ED. The cell membrane sodium pump as a mechanism for increasing thermogenesis during cold acclimation in rats. Science 1977 196: 908 910.
19. Bray GA, York DA, Yukimura Y. Activity of (Na+,K+)-ATPase in the liver of animals with experimental obesity. Life Sci 1978 22: 1637 1642.
20. Lin MH, Romson DR, Akera T, Leveille GA. Na+,K+-ATPase enzyme units in skeletal muscle from lean and obese mice. Biochem Biophys Res Commun 1978 80: 398 404.
21. York DA, Bray GA, Yukimura Y. An enzymatic defect in the obese (ob/ob) mouse: loss of thyroid-induced sodium- and potassium-dependent adenosine triphosphatase. Proc Natl Acad Sci USA 1978 75: 477 481.
22. Iannello S, Campione R, Volpicelli G, Prestipino M, Belfiore F. Na,K-Adenosine triphosphatase in mouse and human obesity and diabetes, as related to insulin, NEFA and hypertension. Diabetologia 1994 37 (Suppl 1 A133.
23. Zemel MB, Sowers JR, Shehin S, Walsh MF, Levy J. Impaired calcium metabolism associated with hypertension in Zucker obese rats. Metabolism 1990 39: 704 708.
24. Belfiore F, Iannello S, Rabuazzo AM, Borzì V. The activity of sodium and potassium-activated adenosine-triphosphatase (Na,K-ATPase) in the adipose tissue of obese patients. In: Enzi G, Crepaldi G, Pozza G, Renold AE (eds). Obesity: Pathogenesis and Treatment. Academic Press: New York and London, 1981, pp. 129 134.
25. DeLuise M, Blackburn GL, Flier JS. Reduced activity of the red cell sodium-potassium pump in human obesity. N Engl J Med 1980 303: 1017 1022.
26. Klimes I, Nagulesparan M, Unger RH, Aronoff SL, Mott DM. Reduced Na+,K+-ATPase activity in intact red cells and isolated membranes from obese man. J Clin Endocrinol Metab 1982 54: 721 724.
27. Kelly RA, O'Hara DS, Mitch WE, Smith TW. Identification of NaK-ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids. J Biol Chem 1986 261: 11704 11711.
28. Swarts HGP, Timmermans JAH, Schuurmans Stekhoven FMAH, De Pont JJHHM, Grafsma SJ, Thien TA. Non-esterified fatty acids and the circulating inhibitor of Na,K-ATPase. In: Skou JC, Norby JG, Maunsbach AB, Esmann M (eds). The Na+,K+-Pump. Part B: Cellular Aspects. Alan R Liss Inc: New York, 1988, pp. 443 448.
29. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 37: 1595 1607.
30. Bjorntorp P. Abdominal obesity and the metabolic syndrome. Ann Med 1992 24: 465 468.
31. Okamoto K, Wang W, Rounds J, Chambers EA, Jacobs DO. ATP from glycolysis is required for normal sodium homeostasis in resting fast-twitch rodent skeletal muscle. Am J Physiol Endocrinol Metab 2001 281: E479 E488.
32. Aperia A. Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility. Curr Hypertens Rep 2001 3: 165 171.
33. Goran MI. Genetic influences on human energy expenditure and substrate utilization. Behav Genet 1997 27: 389 399.
34. Trachtenberg MC, Packey DJ, Sweeney T. In vivo functioning of the Na+-K+-activated ATPase. Curr Top Cell Regul 1981 19: 159 217.
35. Gick GG, Ismail-Beigi F, Edelman IS. Overview: hormonal regulation of Na,K-ATPase. In: Skou JC, Norby JG, Maunsbach AB, Esmann M (eds). The Na+,K+-Pump, Part B: Cellular Aspects. Alan R Liss Inc: New York, 1988, pp. 277 295.
36. Katz AI. Role of Na-K-ATPase in kidney function. Prog Clin Biol Res 1988 268: B207 B232.
37. Ismail-Beigi F, Haber RS, Loeb JN. Stimulation of acute Na+ and K+ transport by thyroid hormone in a rat liver cell line: role of enhanced Na+ entry. Endocrinology 1986 119: 2527 2536.
38. Clausen T. Na+-K+ pump regulation and skeletal muscle contractility. Physiol Rev 2003 83: 1269 1324.
39. Kjeldsen K, Norgaard A, Gotzsche CO, Thomassen A, Clausen T. Effect of thyroid function on number of Na-K-pump in human skeletal muscle. Lancet 1984 2: 8 10.
40. Khan FA, Baron DN. Ion flux and Na+,K+-ATPase activity of erythrocytes and leucocytes in thyroid disease. Clin Sci 1984 72: 171 179.
41. Michels RC, Ober KP, Hennessy JF. Cation transport in intact erythrocytes of hyperthyroid patients: role of the Na,K-ATPase pump. Horm Metab Res 1981 13: 635 638.
42. DeLuise M, Flier JS. Status of the red cell Na,K-pump in hyper- and hypothyroidism. Metabolism 1983 32: 25 30.
43. Del Compare JA, Aguirre JA, Ibarra FR, Barontini M, Armando I. Effects of thyroid hormone on the renal dopaminergic system. Endocrine 2001 15: 297 303.
44. Luo L, MacLean DB. Effects of thyroid hormone on food intake, hypothalamic Na/K ATPase activity and ATP content. Brain Res 2003 973: 233 239.
45. Hendler ED, Torretti J, Kupor L, Epstein FH. Effects of adrenalectomy and hormone replacement on Na,K-ATPase in renal tissue. Am J Physiol 1972 222: 754 760.
46. Sinha SK, Rodriguez HJ, Hogan WC, Klahr SC. Mechanisms of activation of renal (Na+-K+)-ATPase in the rat. Effects of acute and chronic administration of dexamethasone. Biochim Biophys Acta 1981 641: 20 35.
47. Rayson BM, Gupta RK. Steroids, intracellular sodium levels, and Na+/K+-ATPase regulation. J Biol Chem 1985 260: 12740 12743.
48. Stern N, Beck FW, Chandler DW, Mayes DM, Sowers JR. The role of corticosteroids in the regulation of myocardial Na, K-ATPase in normotensive and spontaneously hypertensive rats. Clin Sci 1984 66: 421 426.
49. Mujais SK, Chekal MA, Jones WJ, Hayslett JP, Katz AI. Regulation of renal Na-K-ATPase in the rat. Role of the natural mineralo- and glucocorticoid hormones. J Clin Invest 1984 73: 13 19.
50. Sekihara H, Yazaki Y, Kojima T. Ouabain as an amplifier of mineralocorticoid-induced hypertension. Endocrinology 1992 131: 3077 3082.
51. Greig ER, Mathialahan T, Boot-Handford RP, Sandle GI. Molecular and functional studies of electrogenic Na(+) transport in the distal colon and rectum of young and elderly subjects. Gut 2003 52: 1607 1615.
52. Osore H, Gilbert J. The action of aldosterone and ouabain on cation concentrations in incubated renal slices. Biochem Pharmacol 1982 31: 2571 2574.
53. Diez J. Absence of effect of aldosterone on sodium efflux catalyzed by the human erythrocyte Na+,K+-ATPase in vitro. J Steroid Biochem 1987 27: 963 966.
54. Seok JH, Kim JB, Hong JH, Hur GM, Jeon JR, Lim K, Hwang BD, Lee JH. Aldosterone stimulates Na,K-ATPase activity in basolateral membrane of rat kidney. Biochem Mol Biol Int 1998 45: 879 885.
55. Ikeda U, Hyman R, Smith TW, Medford RM. Aldosterone-mediated regulation of Na(+),K(+)-ATPase gene expression in adult and neonatal rat cardiocytes. J Biol Chem 1991 266: 12058 12066.
56. Summa V, Camargo SM, Bauch C, Zecevic M, Verrey F. Isoform specificity of human Na(+),K(+)-ATPase localization and aldosterone regulation in mouse kidney cells. J Physiol 2004 555: 355 364.
57. Meister B, Aperia A. Molecular mechanisms involved in catecholamine regulation of sodium transport. Semin Nephrol 1993 13: 41 49.
58. Luly P, Barnabei O, Tria E. Hormonal control in vitro of plasma membrane-bound Na-K-ATPase of rat liver. Biochim Biophys Acta 1972 282: 447 452.
59. Desaiah D, Ho IK. Kinetics of catecholamine sensitive Na+-K+-ATPase activity in mouse brain synaptosomes. Biochem Pharmacol 1977 26: 2029 2035.
60. Wu PH, Phillis JW. Characterization of receptor-mediated catecholamine activation of rat brain cortical Na+-K+-ATPase. Int J Biochem 1980 12: 353 359.
61. Clausen T, Hansen O. The effect of cathecholamines on Na-K transport and membrane potential in rat soleus muscle. J Physiol 1977 270: 383 414.
62. Haag M, Gevers W, Bohmer RG. The interaction between calcium and the activation of Na+,K+-ATPase by noradrenaline. Mol Cell Biochem 1985 66: 111 116.
63. Cook LS, Straub KD, Doherty JE, Whittle JL, Baker BJ. Digitalis-sensitive Na+,K+-ATPase: lack of a direct catecholamine-mediated stimulation in bovine myocardial tissue. J Cardiovasc Pharmacol 1983 5: 446 449.
64. Chinet A, Clausen T, Girardier L. Microcalorimetric determination of energy expenditure due to active Na-K transport in the soleus muscle and brown adipose tissue of the rat. J Physiol 1977 265: 43 61.
65. Rothwell NJ, Saville ME, Stock MJ, Wyllie MG. Catecholamine and thyroid hormone influence on brown fat Na+, K+-ATPase activity and thermogenesis in the rat. Horm Metab Res 1982 14: 261 265.
66. Nanberg E, Nedergaard J, Cannon B. Alpha-adrenergic effects on 86Rb+ (K+) potentials and fluxes in brown fat cells. Biochim Biophys Acta 1984 804: 291 300.
67. Himms-Hagen J. Brown adipose tissue metabolism and thermogenesis. Annu Rev Nutr 1985 5: 69 94.
68. LaNoue KF, Koch C, Strzelecka D, Kobylski TP. Regulation of Na+ transport in brown adipose tissue. Biochem J 1986 235: 545 552.
69. Kelly JM, McBride BW. The sodium pump and other mechanisms of thermogenesis in selected tissues. Proc Nutr Soc 1990 49: 185 202.
70. Knehans AW, Romsos DR. Effects of thyroxine on Na+,K+-ATPase and norepinephrine turnover in brown adipose tissue of obese (ob/ob) mice. Metabolism 1984 33: 652 657.
71. Powis DA, Madsen GM. Unsuitability of the 86Rb+ uptake method for estimation of (Na+,K+)-ATPase activity in innervated tissues. Biochim Biophys Acta 1986 861: 251 258.
72. Aperia A, Bertorello A, Seri I. Dopamine causes inhibition of Na+-K+-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 1987 252: F39 F45.
73. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000 62: 621 647.
74. Odlind C, Fasching A, Liss P, Palm F, Hansell P. Changing dopaminergic activity through different pathways: consequences for renal sodium excretion, regional blood flow and oxygen tension in the rat. Acta Physiol Scand 2001 172: 219 226.
75. Velasco M, Contreras F, Cabezas GA, Bolivar A, Fouillioux C, Hernandez R. Dopaminergic receptors: a new antihypertensive mechanism. J Hypertens 2002 20 (Suppl. 3 S55 S58.
76. Ibarra FR, Cheng SX, Agren M, Svensson LB, Aizman O, Aperia A. Intracellular sodium modulates the state of protein kinase C phosphorylation of rat proximal tubule Na+,K+-ATPase. Acta Physiol Scand 2002 175: 165 171.
77. Asghar M, Kansra V, Hussain T, Lokhandwala MF. Hyperphosphorylation of Na-pump contributes to defective renal dopamine response in old rats. J Am Soc Nephrol 2002 12: 226 232.
78. Trivedi M, Narkar VA, Hussain T, Lokhandwala MF. Dopamine recruits D1A receptors to Na-K-ATPase-rich caveolar plasma membranes in rat renal proximal tubules. Am J Physiol Renal Physiol 2004 287: F921 F931.
79. Lijnen P, Groeseneken D, Lommelen L, M'Buyamba-Kabangu JR, Amery A. In vitro inhibition of renal sodium-potassium ATPase activity by progesterone. Methods Find Exp Clin Pharmacol 1985 7: 347 349.
80. Budu CE, Efendiev R, Cinelli AM, Bertorello AM, Pedemonte CH. Hormonal-dependent recruitment of Na+,K+-ATPase to the plasmalemma is mediated by PKC beta and modulated by [Na+]i. Br J Pharmacol 2002 137: 1380 1386.
81. Rubin MS, Swislocki NI, Sonenberg M. Modification by bovine growth hormone of liver plasma membrane enzymes, phospholipids, and circular dichroism. Arch Biochem Biophys 1973 157: 243 251.
82. Fehlman M, Freychet P. Insulin and glucagon stimulation of (Na+,K+)-ATPase transport activity in isolated rat hepatocytes. J Biol Chem 1981 256: 7449 7453.
83. Kraus-Friedman N, Hummel L, Radominska Pyrek A, Little JM, Lester R. Glucagon stimulation of hepatic Na+,K+-ATPase. Mol Cell Biochem 1982 44: 173 180.
84. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, Rigler R, Jornvall H. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 2000 278: E759 E768.
85. Tsimaratos M, Roger F, Chabardes D, Mordasini D, Hasler U, Doucet A, Martin PY, Feraille E. C-peptide stimulates Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 2003 46: 124 131.
86. Djemli-Shipkolye A, Gallice P, Coste T, Jannot MF, Tsimaratos M, Raccah D, Vague P. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients. Metabolism 2000 49: 868 872.
87. Forst T, De La Tour DD, Kunt T, Pfutzner A, Goitom K, Pohlmann T, Schneider S, Johansson BL, Wahren J, Lobig M, Engelbach M, Beyer J, Vague P. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I. Clin Sci (Colch) 2000 98: 283 290.
88. Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M. C-peptide, Na(+),K(+)-ATPase, and diabetes. Exp Diabesity Res 2004 5: 37 50.
89. Cleland SJ, Petrie JR, Ueda S, Elliott HL, Connell JM. Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease. Clin Exp Pharmacol Physiol 1998 25: 175 184.
90. Skou JC. The Na-K-pump. News Physiol Sci 1992 7: 95 100.
91. DeFronzo RA, Bia M, Smith D. Clinical disorders of hyperkalemia. Annu Rev Med 1982 33: 521 554.
92. Rogus E, Price T, Zierler KL. Sodium plus potassium-activated ouabain-inhibited adenosine triphosphatase from a fraction of rat skeletal muscle and lack of insulin effect on it. J Gen Physiol 1969 54: 188 202.
93. Brodal BP, Jebens E, Oy V, Iversen O-J. Effect of insulin on (Na+,K+)-activated adenosine triphosphatase activity in rat muscle sarcolemma. Nature (London) 1974 249: 41 43.
94. Hundal HS, Marette A, Mitsumoto Y, Ramlal T, Blostein R, Klip A. Insulin induces translocation of the α2 and β1 subunits of the Na,K-ATPase from intracellular compartments to the plasma membranes in mammalian skeletal muscle. J Biol Chem 1992 267: 5040 5045.
95. Erlij F, Grinstein S. The number of sodium ion pumping sites in skeletal muscle and its modification by insulin. J Physiol 1976 259: 13 31.
96. Flatman JA, Clausen T. Combined effects of adrenaline and insulin on active electrogenic Na+,K+ transport in rat soleus muscle. Nature 1979 281: 580 581.
97. Weil E, Sasson S, Gutman Y. Mechanism of insulin-induced activation of Na,K- ATPase in isolated rat soleus muscle. Am J Physiol 1991 261: 224 230.
98. Rosic NK, Standaert ML, Pollet RJ. The mechanism of insulin stimulation of (Na,K+)-ATPase transport activity in muscle. J Biol Chem 1985 260: 6206 6212.
99. Gelehrter TD, Shreve PD, Dilworth VM. Insulin regulation of Na/K pump activity in rat hepatoma cells. Diabetes 1984 33: 428 434.
100. Catalan RE, Martinez AM, Aragones MD, Fernandez I, Miguel BG. Inhibitory effect of insulin and cytoplasmic factor(s) on brain Na,K-ATPase. Neurosci Res 1992 13: 139 145.
101. Gourley DRH, Bethea MD. Insulin effect on adipose tissue sodium and potassium. Proc Soc Exp Biol Med 1964 115: 821 823.
102. Resh MD, Nemenoff RA, Guidotti G. Insulin stimulation of (Na+,K+)-adenosine triphosphatase-dependent 86Rb+ uptake in rat adipocytes. J Biol Chem 1980 255: 10938 10945.
103. Lytton J, Lin JC, Guidotti G. Identification of two molecular forms of (Na+,K+)-ATPase in rat adipocytes. Relation to insulin stimulation of the enzyme. J Biol Chem 1985 260: 1177 1184.
104. McGill DL. Characterization of the adipocyte ghost Na,K-pump. Insights into the insulin regulation of the adipocyte Na,K-pump. J Biol Chem 1991 266: 15817 15823.
105. McGill DL, Guidotti G. Insulin stimulates both the α1 and the α2 isoforms of the rat adipocyte (Na+,K+)-ATPase. J Biol Chem 1991 266: 15824 15831.
106. Feraille E, Marsy S, Cheval L, Barlet-Bas C, Khadouri C, Favre H, Doucet A. Sites of antinatriuretic action of insulin along rat nephron. Am J Physiol 1992 263: F175 F179.
107. Banday AA, Asghar M, Hussain T, Lokhandwala MF. Dopamine-mediated inhibition of renal Na,K-ATPase is reduced by insulin. Hypertension 2003 41: 1353 1358.
108. Lostroh AJ, Krahl ME. Accumulation in vitro of Mg2+ and K+ in rat uterus: ion or pump activity. Biochim Biophys Acta 1973 291: 260 268.
109. Luppa D, Hoenicke S, Reissing D, Mueller F. Effect of alloxan diabetes on Na,K-activated ATPase in the brush border membrane of the mucosal cell of the rat small intestine [German]. Acta Biol Med Ger 1978 37: 39 47.
110. Luly P, Baldini P, Incerpi S, Tria S. Insulin effect in vitro on human erythrocyte plasma membrane. Experientia 1981 37: 431 433.
111. Hadden JW, Hadden EM, Wilson EE, Good RA, Coffey RG. Direct action of insulin on plasma membrane ATPase activity in human lymphocytes. Nat New Biol 1972 235: 174 176.
112. Sowers JR. Effects of insulin and IGF-I on vascular smooth muscle glucose and cation metabolism. Diabetes 1996 45 (Suppl. 3 S47 S51.
113. Anderson EI, Fischbarg J. Biphasic effects of insulin and ouabain on fluid transport across rabbit corneal endotelium. J Physiol (London) 1978 275: 377 389.
114. Simmons DA, Winegrad AI. Insulin does not regulate vascular smooth muscle Na,K-ATPase activity in rabbit aorta. Diabetologia 1993 36: 212 217.
115. Mendoza SA, Wigglesworth NM, Rozengurt E. Vasopressin rapidly stimulates Na entry and Na,K-pump activity in quiescent cultures of mouse 3T3 cells. J Cell Physiol 1980 105: 153 162.
116. Lynch CJ, Wilson PB, Blackmore PF, Exton JH. The hormone-sensitive hepatic Na(+)-pump. Evidence for regulation by diacylglycerol and tumor promoters. J Biol Chem 1986 261: 14551 14556.
117. Sweeney G, Niu W, Kanani R, Klip A. Regulation of the Na,K-pump by leptin in 3T3-L1 fibroblasts. Endocrinology 2000 141: 1277 1280.
118. Beltowski J, Wjcicka G, Gorny D, Marciniak A. Human leptin administered intraperitoneally stimulates natriuresis and decreases renal medullary Na+,K+-ATPase activity in the rat - Impaired effect in dietary-induced obesity. Med Sci Monit 2002 8: BR221 BR229.
119. Beltowski J, Marciniak A, Wojcicka G, Gorny D. Nitric oxide decreases renal medullary Na+,K+-ATPase activity through cyclic GMP-protein kinase G dependent mechanism. J Physiol Pharmacol 2003 54: 191 210.
120. Beltowski J, Jamroz-Wisniewska A, Borkowska E, Nazar J, Marciniak A. Antioxidant treatment normalizes renal Na(+),K(+)-ATPase activity in leptin-treated rats. Pharmacol Rep 2005 57: 219 228.
121. Sacerdoti D, Gatta A, McGiff JC. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology. Prostaglandins Other Lipid Med 2003 72: 51 71.
122. Sarkis A, Roman RJ. Role of cytochrome P450 metabolites of arachidonic acid in hypertension. Curr Drug Metab 2004 5: 245 256.
123. Efendiev R, Krmar RT, Ogimoto G, Zwiller J, Tripodi G, Katz AI, Bianchi G, Pedemonte CH, Bertorello AM. Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res 2004 95: 1100 1108.
124. Glorioso N, Filigheddu F, Cusi D, Troffa C, Conti M, Natalizio M, Argiolas G, Barlassina C, Bianchi G. alpha-Adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives. Hypertension 2002 39: 357 362.
125. Meyer-Lehnert H, Backer A, Kramer HJ. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin. Am J Hypertens 2000 13: 364 369.
126. Ferrandi M, Manunta P. Ouabain-like factor: is this the natriuretic hormone? Curr Opin Nephrol Hypertens 2000 9: 165 171.
127. Schoner W, Bauer N, Muller-Ehmsen J, Kramer U, Hambarchian N, Schwinger R, Moeller H, Kost H, Weitkamp C, Schweitzer T, Kirch U, Neu H, Grunbaum EG. Ouabain as a mammalian hormone. Ann N Y Acad Sci 2003 986: 678 684.
128. Garner T, Haupert MD Jr. Overview: physiological inhibitors of Na,K-ATPase: concept and status. In: Skou JC, Norby JG, Maunsbach AB, Esmann M (eds). The Na+, K+-Pump, Part B: Cellular Aspects. Alan R Liss Inc: New York, 1988, pp. 297 320.
129. Ng LL, Hockaday TD. The effect of environmental temperature on prandial changes in leucocyte sodium transport in man. Br J Nutr 1989 62: 639 645.
130. Dauncey MJ, Burton KA. 3H-ouabain binding sites in porcine skeletal muscle as influenced by environmental temperature and energy intake. Pflugers Arch 1989 414: 317 323.
131. Lupien JR, Glick Z, Saito M, Bray GA. Guanosine diphosphate binding to brown adipose tissue mitochondria is increased after single meal. Am J Physiol 1985 249: R694 R698.
132. Flier JS, Usher P, DeLuise M. Effect of sucrose overfeeding on Na,K-ATPase-mediated 86Rb uptake in normal and ob/ob mice. Diabetes 1981 30: 975 978.
133. Berger ME, Ormsby BL, Bunnag P, Hori MT, Tuck ML, Golub MS. Increased functional Na+-K+-pump activity in the vasculature of fructose-fed hyperinsulinemic and hypertensive rats. Hypertens Res 1998 21: 73 80.
134. Feraille E, Marsy S, Barlet Bas C, Rousselot M, Cheval L, Favre H, Doucet A. Insulin unresponsiveness of tubular monovalent cation transport during fructose-induced hypertension in rats. Clin Sci (Colch) 1995 88: 293 299.
135. Scherzer P, Nachliel I, Bar-On H, Popovtzer MM, Ziv E. Renal Na-K-ATPase hyperactivity in diabetic Psammomys obesus is related to glomerular hyperfiltration but is insulin-independent. J Endocrinol 2000 167: 347 354.
136. Shafrir E. Overnutrition in spiny mice (Acomys cahirinus): beta-cell expansion leading to rupture and overt diabetes on fat-rich diet and protective energy-wasting elevation in thyroid hormone on sucrose-rich diet. Diabetes Metab Res Rev 2000 16: 94 105.
137. Romsos DR. Efficiency of energy retention in genetically obese animals and in dietary-induced thermogenesis. Fed Proc 1981 40: 2524 2529.
138. Rothwell NJ, Saville ME, Stock MJ, Wyllie MG. Influence of thyroid hormone on diet-induced thermogenesis in the rat. Horm Metab Res 1983 15: 394 398.
139. Harper ME, Patrick J, Himms-Hagen J. Altered brown adipose tissue and Na,K pump activities during diet-induced obesity and weight loss in rats. Obes Res 1993 1: 106 117.
140. Fagerberg B, Herlitz H, Jonsson O, Naucler J, Nilsson U, Hedner T, Lindstedt G, Andersson O. Increased erythrocyte sodium efflux during overfeeding without evidence of mediation by circulating catecholamines or thyroid hormone. Metabolism 1984 33: 994 998.
141. Mir MA, Charalombous BM, Morgan K. Erythrocyte sodium-potassium ATPase and obesity. N Engl J Med 1982 306: 809 810.
142. Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension. Circulation 2002 105: 1122 1127.
143. Swann AC. (Na+, K+)-ATPase regulation and NaCl intake: effects on circulating inhibitor and sensitivity to noradrenaline. Clin Sci (Lond) 1985 69: 441 447.
144. Ikari A, Tachihara Y, Kawano K, Suketa Y. Differential regulation of Na(+),K(+)-ATPase and the Na(+)-coupled glucose transporter in hypertensive rat kidney. Biochim Biophys Acta 2001 1510: 118 124.
145. Tsuchida H, Imai G, Shima Y, Satoh T, Owada S. Mechanism of sodium load-induced hypertension in non-insulin dependent diabetes mellitus model rats: defective dopaminergic system to inhibit Na-K-ATPase activity in renal epithelial cells. Hypertens Res 2001 24: 127 135.
146. Lucas-Teixeira VA, Hussain T, Serrao P, Soares da Silva P, Lokhandwala MF. Intestinal dopaminergic activity in obese and lean Zucker rats: response to high salt intake. Clin Exp Hypertens 2002 24: 383 396.
147. Silva P, Hayslett JP, Epstein FH. The role of Na-K-activated adenosine triphosphatase in potassium adaptation: stimulation of enzymatic activity by potassium loading. J Clin Invest 1973 52: 2665 2671.
148. Haga H. Effects of dietary magnesium supplementation on diurnal variations of blood pressure and plasma Na+,K(+)-ATPase activity in essential hypertension. Jpn Heart J 1992 33: 785 800.
149. Ahmed K, Thomas BS. The effects of long-chain fatty acids on sodium plus potassium ion-stimulated adenosine triphosphatase of rat brain. J Biol Chem 1971 246: 103 109.
150. Tamura M, Kuvano H, Kinoshita T, Inagami T. Identification of linoleic and oleic acids as endogenous Na+,K+-ATPase inhibitors from acute volume -expanded hog plasma. J Biol Chem 1985 260: 9672 9877.
151. Huang W-H, Xie Z, Kakar SS, Askari A. Control of the sodium pump by liponucleotides and unsaturated fatty acids: side-dipendent effects in red cells. In: Skou JC, Norby JG, Maunsbach AB, Esmann M (eds). The Na+,K+-Pump. Part B: Cellular Aspects. Alan R Liss Inc: New York, 1988, pp. 277 295.
152. Guernsey DL, Morishige HK. Na+ pump activity and nuclear T3 receptors in tissues of genetically obese (ob/ob) mice. Metabolism 1979 28: 629 632.
153. Elmi A. Increased number of Na+/K+ ATPase enzyme units in ob/ob-mouse pancreatic islets. Pancreas 2001 23: 113 115.
154. Ferrer Martinez A, Felipe A, Casado EJ, Pastor Anglada M. Differential regulation of Na+-K+-ATPase in the obese Zucker rat. Am J Physiol 1996 271: R1123 R1129.
155. Bickel CA, Verbalis JG, Knepper MA, Ecelbarger CA. Increased renal Na-K-ATPase, NCC, and beta-ENaC abundance in obese Zucker rats. Am J Physiol Renal Physiol 2001 281: F639 F648.
156. Banday AA, Hussain T, Lokhandwala MF. Renal dopamine D (1) receptor dysfunction is acquired and not inherited in obese Zucker rats. Am J Physiol Renal Physiol 2004 287: F109 F116.
157. Klimes I, Howard BV, Mott DM. Sodium-potassium pump in cultured fibroblasts from obese donors; no evidence for an inherent decrease of basal or insulin-stimulated activity. Metabolism 1984 33: 317 322.
158. Simat BM, Mayrand RR, From AHL, Morley JE, Billington C, Fullerton DS, Ahmed K. Is the erythrocite sodium pump altered in human obesity? J Clin Endocrinol Metab 1983 56: 925 929.
159. Mott DM, Clark RL, Andrews WJ, Foley JE. Insulin-resistant Na+ pump activity in adipocytes from obese humans. Am J Physiol 1985 249: E160 E164.
160. Das RK, Muddeshwar MG. Alteration in the activities of the membrane-integrated enzymes of polymorphonuclear leukocytes in obesity. Indian Heart J 1997 49: 521 524.
161. Bray GA, Kral JG, Bjorntorp P. Hepatic sodium-potassium dependent ATPase in obesity. N Engl J Med 1981 304: 1580 1582.
162. DeLuise M, Rappaport E, Flier JS. Altered erythrocyte Na+-K+-pump in adolescent obesity. Metabolism 1982 31: 1153 1158.
163. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991 14: 173 194.
164. Tack CJ, Lutterman JA, Vervoort G, Thien T, Smits P. Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans. Hypertension 1996 28: 426 432.
165. Mazelis AG, Larson S, Ginsberg-Fellner F. Erythrocyte Na,K-ATPase activity in childhood: regulation by genetic factors independent of body weight. Int J Obesity 1987 11: 561 570.
166. Bozzo C, Goria M, Marena S, Avagnina S, Pagano G. Lymphocyte (Na,K)-ATPase-dependent 86Rb+ uptake in human obesity. Diabetes Metab 1988 14: 646 652.
167. Sowers JR, Whitfield LA, Beck FWJ. Role of enhanced sympathetic nervous system activity and reduced Na,K-dependent adenosine triphosphatase activity in maintenance of elevated blood pressure in obesity: effect of weight loss. Clin Sci 1982 63 (Suppl. 8 S121 S124.
168. Narayanareddy K, Kaplay SS. Inverse relationship between ouabain sites on human erythrocytes and body mass index in normal healthy subjects. Metabolism 1983 32: 722 727.
169. Iannello S, Campione R, Belfiore F. Response of insulin, glucagon, lactate and non-esterified fatty acids to glucose in visceral obesity with and without NIDDM. Relationship to hypertension. Mol Genet Metab 1998 63: 214 223.
170. Bray GA, York DA. Genetically transmitted obesity in rodents. Physiol Rev 1971 51: 598 646.
171. Bevilacqua S, Bonadonna R, Buzzigoli G, Boni C, Ciociaro D, Maccari F, Giorico MA, Ferrannini E. Acute elevation of free acid levels leads to hepatic insulin resistance in obese subjects. Metabolism 1987 36: 502 506.
172. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989 83: 1168 1173.
173. Baynes C, Henderson AD, Hughes CL, Richmond W, Johnston DG, Elkeles RS. Determinants of mild fasting hypertriglyceridaemia in non-insulin-dependent diabetes. J Intern Med 1991 229: 267 273.
174. Iannello S, Bosco P, Cavaleri A, Camuto M, Milazzo P, Belfiore F. A review of the literature of the Bardet-Biedl disease and report of three cases associated with metabolic syndrome and diagnosed after the age of fifty. Obes Rev 2002 3: 123 135.
175. Iannello S, Bosco P, Camuto M, Cavaleri A, Milazzo P, Belfiore F. A mild form of Alstrom disease associated with metabolic syndrome and very high fasting serum FFA. Two case diagnosed in adult age. Am J Med Sci 2004 327: 284 288.
176. Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987 316: 599 606.
177. Simmons D, Winegrad AI. Mechanism of glucose-induced (Na+,K+)-ATPase inhibition in aortic wall of rabbits. Diabetologia 1989 32: 402 408.
178. Cohen MP, Klepser H. Glomerular Na+,K+-ATPase activity in acute and chronic diabets and with aldose reductase inhibition. Diabetes 1988 37: 558 562.
179. Ku DD, Meezan E. Increased renal tubular sodium pump and Na+,K+-adenosine triphosphatase in streptozotocin diabetic rats. J Pharmacol Exp Ther 1984 229: 664 670.
180. Wald H, Popovtzer MM. The effect of streptozotocin-induced diabetes mellitus on urinary excretion of sodium and renal NA+/K+-ATPase activity. Pfluegers Arch 1984 401: 97 100.
181. Levy J, Avioli LV, Roberts ML, Gavin JR III. (Na-K)-ATPase activity in basolateral membranes of non-insulin-dependent diabetic rats. Biochem Biophys Res Commun 1986 139: 1313 1319.
182. Finegold DN, Strychor S. Renal ouabain inhibitable Na-K ATPase activity and myoinositol supplementation in experimental diabetes mellitus. Metabolism 1988 37: 557 561.
183. Wald H, Scherzer P, Rasch R, Popovtzer MM. Renal tubular Na,K-ATPase in diabetes mellitus: relationship to metabolic abnormality. Am J Physiol 1993 265: E96 E101.
184. Kowluru RA, Engerman RL, Kern TS. Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy. Free Radic Res 2000 32: 67 74.
185. Ng YC, Tolerico PH, Book CB. Alterations in levels of Na,K-ATPase isoforms in heart, skeletal muscle, and kidney in diabetic rats. Am J Physiol 1993 265: E243 E251.
186. Kowluru R, Bitensky MW, Kowluru A, Dembo M, Keaton PA, Buican T. Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects of filterability and implications for microangiopathy. Proc Natl Acad Sci USA 1989 86: 3327 3331.
187. Reddi AS, Dasmahapatra A, Jyothirmayi GN, Jayasundaramma B. Erythrocyte Ca, Na,K-ATPase in long-term streptozotocin diabetic rats. Effect of good glycemic control and a Ca antagonist. Am J Hypertens 1992 5: 863 868.
188. Agarwal VR, Rastogi AK, Sahib MK, Sagar P. In vitro insulin action of different ATPases of erythrocyte membranes in normal and diabetic rats. Acta Diabetol Lat 1985 22: 111 118.
189. Sennoune S, Gerbi A, Duran MJ, Grillasca JP, Compe E, Pierre S, Planells R, Bourdeaux M, Vague P, Pieroni G, Maixent JM. Effect of streptozotocin-induced diabetes on rat liver Na+/K+-ATPase. Eur J Biochem 2000 267: 2071 2078.
190. Michea L, Irribarra V, Goecke IA, Marusic ET. Reduced Na-K pump but increased Na-K-2Cl cotransporter in aorta of streptozotocin-induced diabetic rat. Am J Physiol Heart Circ Physiol 2001 280: H851 H858.
191. Marwaha A, Banday AA, Lokhandwala MF. Reduced renal dopamine D1 receptor function in streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol 2004 286: F451 F457.
192. Smith JM, Solar SM, Paulson DJ, Hill NM, Broderick TL. Effect of palmitate on carbohydrate utilization and Na/K-ATPase activity in aortic vascular smooth muscle from diabetic rats. Mol Cell Biochem 1999 194: 125 132.
193. Djurhuus MS, Henriksen JE, Klitgaard NA. Magnesium, sodium, and potassium content and [3H]-ouabain binding capacity of skeletal muscle in relatives of patients with type 2 diabetes: effect of dexamethasone. Metabolism 2002 51: 1331 1339.
194. Jannot MF, Raccah D, De La Tour DD, Coste T, Vague P. Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients. Metabolism 2002 51: 284 291.
195. Mimura M, Makino H, Kanatsuka A, Asai T, Yoshida S. Reduction of erythrocyte Na+,K+-ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Horm Metab Res 1994 26: 33 38.
196. Nagamatsu S, Inoue N, Murakawa S, Matsui H. Evaluation of sodium and potassium pump activity and number in diabetic erythrocytes. Acta Endocrinol (Copenh) 1986 11: 69 74.
197. Baldini P, Incerpi S, Lambert-Gardini S, Spinedi A, Luly P. Membrane lipid alterations and Na+-pumping activity in erythrocytes from IDDM and NIDDM subjects. Diabetes 1989 38: 825 831.
198. Finotti P, Palatini P. Reduction of erythrocyte Na,K-ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. Diabetologia 1986 29: 623 628.
199. Rabini RA, Fumelli P, Staffolani R, Mazzanti L, Pugnaloni A, Biagini G, Faloia E, De Pirro R. Effects of diabetes mellitus on structural and functional properties of erythrocyte membranes. Membr Biochem 1993 10: 71 79.
200. Issautier T, Kovacic H, Gallice P, Raccah D, Vague P, Crevat A. Modulation defect of the sodium pump evidenced in diabetic patients by a microcalorimetric study. Clin Chim Acta 1994 228: 161 170.
201. Mazzanti C, Rabini RA, Faloia E, Fumelli P, Bertoli E, De Pirro R. Altered cellular Ca2+ and Na+-transport in diabetes mellitus. Diabetes 1990 39: 850 854.
202. Bergstrom B, Mattiason I, Rosen I, Lilja B, Sundkvist G. Platelet sodium and potassium ATPase activity and noradrenaline efflux rate in relation to autonomic and peripheral nerve function in insulin-dependent diabetic patients. J Intern Med 1989 225: 185 190.
203. Graves SW. The sodium pump in hypertension. Curr Opin Nephrol Hypertens 1994 3: 107 111.
204. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 1987 317: 350 357.
205. Reaven GM, Hoffman BB. A role for insulin in the aetiology and course of hypertension. Lancet 1987 II: 435 437.
206. Halkin H, Modan M, Shefi M, Almog S. Altered erythrocyte and plasma sodium and potassium in hypertension, a facet of hyperinsulinemia. Hypertension 1988 11: 71 77.
207. O'Hare JA. The enigma of insulin resistance and hypertension. Insulin resistance, blood pressure and the circulation. Am J Med 1988 84: 505 510.
208. Ferrari P, Weidmann P. Insulin, insulin sensitivity and hypertension. J Hypertens 1990 8: 491 500.
209. Eriksson KF, Lindgarde F. Contribution of estimated insulin resistance and glucose intolerance to essential hypertension. J Intern Med 1991 735 (Suppl. 75 83.
210. Christlieb AR, Krolewski AS, Warram JH, Soeldner JS. Is insulin the link between hypertension and obesity? Hypertension 1985 7 (Suppl. II II54 II58.
211. Lucas CP, Estigarribia JA, Darga LL, Reaven GM. Insulin and blood pressure in obesity. Hypertension 1985 7: 702 706.
212. Modan M, Halkin H, Almog S, Lusky A, Eshkil M, Shitrit A, Fuchs A. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985 75: 809 817.
213. Izzo JL, Swislocki ALM. Workshop III - Insulin resistance: is it truly the link? Am J Med 1991 90 (Suppl. 2 26 31.
214. Van Winkle LJ. Hypertension, obesity, and sodium-potassium transport. N Engl J Med 1981 304: 358 359.
215. Webster DP, Van Winkle LJ, Karrat JJ. Erythrocyte ouabain binding and intracellular Na+ in normotensive obese women and obese women receiving medication for hypertension. Biochem Med 1984 32: 232 241.
216. Mattiasson I, Berntorp K, Lindgarde F. Insulin resistance and Na,K-ATPase in hypertensive women; a difference in mechanism depending on the level of glucose tolerance. Clin Sci 1992 82: 105 111.
217. Jannot MF, Raccah D, Dufayet de la Tour D, Coste T, Gouvernet J, Vague P. Relationship between neuropathy, hypertension and red blood cell Na/K ATPase in patients with insulin-dependent diabetes mellitus. Diabetes Metab 1999 25: 35 42.
218. Pamnani MB, Chen S, Haddy FJ, Yuan C, Mo Z. Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes and simulated weightlessness in rats. Clin Exp Hypertens 1998 20: 509 521.
219. Chan JC, Butt A, Ho CS, Cockram C, Swaminathan R. Relation between blood pressure and serum concentration of ouabain-like substance in non-insulin-dependent diabetes mellitus [letter]. Lancet 1998 351: 266.
220. Martinka E, Ocenasova A, Kamenistiakova L, Dobrota D, Kerny J, Mokan M. Endogenous digoxin-like immunoactivity in subjects with diabetes mellitus and hypertension. Am J Hypertens 1998 11: 667 676.
221. Giampietro O, Clerico A, Penno G, Gregori G, Del Chicca MG, Cionini R, Volpe L, Navalesi R. Endogenous digitalis-like factors (EDLF) in obese individuals: preliminary results. J Nucl Biol Med 1992 36: 41 45.
222. Carroll JS, Seely EW, Tao QF, Graves SW. Digitalis-like factor response to hyperinsulinemia accompanying an euglycemic hyperinsulinemic clamp or oral glucose tolerance test. Life Sci 2001 69: 829 837.
223. Egan BM, Hennes MM, Stepniakowski KT, O'Shaughnessy IM, Kissebah AH, Goodfriend TL. Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension 1996 27: 723 728.
224. Filipovsky J, Ducimetiere P, Eschwege E, Richard JL, Rosselin G, Claude JR. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens 1996 14: 229 235.
225. Grekin RJ, Vollmer AP, Sider RS. Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension. Hypertension 1995 26: 193 198.
226. Pasquali R, Strocchi E, Malini P, Casimirri F, Melchionda N, Ambrosini E, Labò G. Heterogeneity of the erythrocyte Na-K-pump status in human obesity. Metabolism 1985 34: 802 807.
227. Mazzanti L, Rabini RA, Testa I, Bertoli E. Modifications induced by diabetes on the physicochemical and functional properties of erythrocyte plasma membrane. Eur J Clin Invest 1989 19: 84 89.
228. Blostein R, Grafova E. Loss of Na,K-ATPase during sheep reticulocyte maturation. In: Skou JC, Norby JG, Maunsbach AB, Esmann M (eds). The Na+,K+-Pump, Part B: Cellular Aspects. Alan R Liss Inc.: New York and London, 1988, pp. 357 364.
229. Gambert SR, Duthie EH Jr. Effect of age on red cell membrane sodium-potassium dependent adenosine triphosphatase (Na+-K+ ATPase) activity in healthy men. J Gerontol 1983 38: 23 25.
230. Bozzo C, Goria M, Marengo C, Morena S, Veglia F, Pagano G. Lymphocyte Na,K-ATPase is reduced in aged people. Metabolism 1990 33: 808 814.